Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT00908037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Purpura, Thrombocytopaenic, Idiopathic

Interventions

DRUG: eltrombopag
DRUG: Placebo

Sponsor

GlaxoSmithKline